Healthcare -
Medical - Diagnostics & Research - NYSE - US
$ 0.6075
1.28 %
$ 31.7 M
Market Cap
-4.05
P/E
ENZ - COST OF REVENUE
Cost of Revenue ENZ - Enzo Biochem, Inc.
17.3 M
LAST VALUE
-48.49%
2 YEAR CAGR
-21.49%
5 YEAR CAGR
-10.82%
10 YEAR CAGR